Financials data is unavailable for this security.
View more
Year on year Molecure SA 's revenues fell -18.85% from 1.61m to 1.31m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 15.30m to a larger loss of 18.31m.
Gross margin | -444.01% |
---|---|
Net profit margin | -6,082.40% |
Operating margin | -6,902.23% |
Return on assets | -18.17% |
---|---|
Return on equity | -20.16% |
Return on investment | -19.29% |
More ▼
Cash flow in PLNView more
In 2023, Molecure SA did not generate a significant amount of cash. Cash Flow from Financing totalled 54.74m or 4,182.92% of revenues. In addition the company used 11.60m for operations while cash used for investing totalled 44.76m.
Cash flow per share | -1.24 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 5.59 |
---|---|
Tangible book value per share | 2.95 |
More ▼
Balance sheet in PLNView more
Current ratio | 5.79 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0703 |
---|---|
Total debt/total capital | 0.0657 |
More ▼